πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8828717

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8829008

Organic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8828652

Elimination of N-glycolylneuraminic acid from animal products for human use

The Regents of the University of California Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809269

Therapeutic agent preparations comprising insulin for delivery into a lumen of the intesti

Rani Therapeutics, LLC Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809271

Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the int

Rani Therapeutics, LLC Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8790890

Diagnostic method for connective tissue and its application

OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU β€œNTLAB-SC” Β· Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785633

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8764733

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a s

Rani Therapeutics, LLC Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8758778

Polymeric nano-carriers with a linear dual response mechanism and uses thereof

The Regents of the University of California Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8759284

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a s

Rani Therapeutics, LLC Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8754046

MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8734429

Device, system and methods for the oral delivery of therapeutic compounds

Rani Therapeutics, LLC Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8734808

Isolation of a virus related to canine parvovirus-2 from a raccoon

The Board of Regents for Oklahoma State University Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728524

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the preventi

Anika Therapeutics S.r.l. Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations an

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8721620

Swallowable drug delivery device and methods of drug delivery

Rani Therapeutics, LLC Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715710

Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

Heron Therapeutics, Inc. Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715949

Applications of the binding interaction of proanthocyanidins with bacteria and bacterial c

United States of America as represented by the Secretary of the Air Force Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658154

Humanized FcΞ³R mice

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653055

Corticosteroid having low systemic absorption

Teva Animal Health, Inc. Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8653027

Method of treatment of type-1 diabetes with humanin analogues

The Regents of the University of California Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8647637

Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circu

The Board of Regents for Oklahoma State University Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642784

Biologically active compound N-[3-(4-nitrophenylamino)-indole-2-ilmethylene]aminoguanidine

Obschestvo S Ogranichennoy Otvetstvennostyu β€œPolyar” (OOO Polyar) Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637470

Small humanin-like peptides

The Regents of the University of California Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted